Literature DB >> 617073

The use of bromocriptine in the galactorrhoea-amenorrhoea syndromes: the Canadian cooperative study.

H G Friesen, G Tolis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 617073     DOI： 10.1111/j.1365-2265.1977.tb03343.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  13 in total

1.  Hyperprolactinemia in anovulatory women. Incidence and endocrine features.

Authors:  A S Wolf; K Musch; C Lauritzen
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

Review 2.  Pharmacologic resistance in prolactinoma patients.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

3.  [Clinical endocrine investigations in patients with pituitary adenoma (author's transl)].

Authors:  D Mühlenstedt; J Hanker; H P Schneider
Journal:  Arch Gynakol       Date:  1978-07-19

4.  Nasal spray vs oral administration of bromocriptine: pharmacology and effect on serum prolactin in puerperal women.

Authors:  E Cicinelli; M Cignarelli; D Petruzzi; M G Matteo; C Ruccia; L M Schonauer
Journal:  J Endocrinol Invest       Date:  1996 Jul-Aug       Impact factor: 4.256

5.  Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma).

Authors:  M Berezin; I Shimon; M Hadani
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

Review 6.  Use of bromocriptine in hyperprolactinaemic anovulation and related disorders.

Authors:  S Franks
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

Review 7.  Dopamine resistance of prolactinomas.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

8.  Prolactin oversuppression.

Authors:  H G Bohnet; D Mühlenstedt; J P Hanker; H P Schneider
Journal:  Arch Gynakol       Date:  1977-10-28

9.  Cushing's disease: clinical and laboratory response to bromocriptine therapy.

Authors:  M O de Pinho; R C Antunes; M B Lima; C C Francalanci; S Franco
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

10.  Treatment of patients with prolactinomas.

Authors:  K v Werder; R Fahlbusch; R Landgraf; C R Pickardt; H K Rjosk; P C Scriba
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.